What is Biogen's total equity?

Biogen (BIIB) reported total equity of $18.65B in Q1 2026.

How has Biogen's total equity changed year-over-year?

Biogen's total equity increased by 9.9% year-over-year, from $16.98B to $18.65B.

What is the long-term trend for Biogen's total equity?

Over 5 years (2020 to 2025), Biogen's total equity has grown at a 11.3% compound annual growth rate (CAGR), from $10.7B to $18.26B.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

Biogen BIIB Total Equity

Total Equity at other companies

Eli LillyLLY

$31.2B+97.9%

Rogers CorporationROG

$1.19B-6.1%

TG TherapeuticsTGTX

$583.13M+146%

Acadia PharmaceuticalsACAD

$1.25B+63.1%

AnaptysBio, Inc.ANAB

$12.75M-62.5%

Syndax PharmaceuticalsSNDX

$41.62M-80.6%

Other financials

Income statement

See full

Revenue$2.5B+1.9%

Gross profit$1.8B+0.8%

Operating income$610.7M—

Net income$319.5M+32.8%

EPS (diluted)$2.15+31.1%

Balance sheet

See full

Cash & equivalents$3.4B+30.2%

Total debt$6.6B+34.7%

Total assets$29.5B+5.2%

Cash flow

See full

Operating cash flow$645.5M+149%

CapEx$51.2M+38.0%

Free cash flow$594.3M+167%

Valuation

See full

Market cap$31.9B+71.6%

Enterprise value$35.08B+56.4%

P/E22.5×+10.3×

P/S3.2×+1.4×

Profitability

See full

Gross margin75.5%-0.1pp

Operating margin22.9%—

Net margin14.3%-0.8pp

FCF margin24.4%-0.4pp

Returns & leverage

See full

Return on equity8%-1.2pp

Debt / equity0.4×+0.1×

Current ratio3.1×+1.6×

Where this comes from

Reported directly by Biogen in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest.

The official record: Biogen’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biogen's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biogen's total equity?: Biogen (BIIB) reported total equity of $18.65B in Q1 2026.
How has Biogen's total equity changed year-over-year?: Biogen's total equity increased by 9.9% year-over-year, from $16.98B to $18.65B.
What is the long-term trend for Biogen's total equity?: Over 5 years (2020 to 2025), Biogen's total equity has grown at a 11.3% compound annual growth rate (CAGR), from $10.7B to $18.26B.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.